Search
Biofrontera Inc
BFRIAdd to Watchlist
0.789USD
+0.008+1.02%
Close 10-23 16:00（ET）
11.72MMarket Cap
LossP/E TTM
Biofrontera Inc (BFRI) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Biofrontera Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
6.000USD+630.28%
BFRI Analyst Recommendation Trends
In the current month, BFRI has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BFRI average Analyst price target in the last month is 6.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
BFRI Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
Financial Forecasting
Based on analysts' estimates, BFRI EPS is projected to reach -0.220 in FY2026Q3, following reported EPS of -0.047 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.20
-0.12
-0.10
-0.22
0.23
Actual
0.48
-0.41
-0.05
--
--
Surprise
+147.96%
-253.68%
+55.49%
--
--
FAQs
What is Biofrontera Inc's expected revenue for the next quarter?
Biofrontera Inc's expected revenue is 8.25M.
What is Biofrontera Inc's price target?
Analysts forecast that Biofrontera Inc's price target is USD 6.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 3.00.
How have Biofrontera IncBFRI's recent earnings per share performed?
The market expectation was USD -0.05, while Biofrontera IncBFRI's earnings per share (EPS) for the previous quarter was USD -0.41. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for Biofrontera Inc?
Based on the ratings of Biofrontera Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.